Gene Expression After Asbestos Exposure Explains Development of Malignant Mesothelioma | Newswise

Gene Expression After Asbestos Exposure Explains Development of Malignant Mesothelioma | Newswise

Philadelphia, PA — Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant Pleural Mesothelioma (MPM), a rare and aggressive cancer. By analyzing public RNA-seq data through a comprehensive bioinformatics pipeline, scientists working with the Sbarro Health Research Organization (SHRO) have developed an in-depth view of the…

Read More
New Study Finds that Physical Pressure Escalates Liver Cancer Aggression | Newswise

New Study Finds that Physical Pressure Escalates Liver Cancer Aggression | Newswise

Newswise — Yale researchers are providing new insights into how physical forces, such as cells being compressed in physically restrictive environments, play key roles in cancer progression. By analyzing liver cancer cells, the researchers found that these cells have a dense tissue matrix, which causes crowding and significant compression within tumors. This physical stress sparks…

Read More
UC Davis Clinical Trial Shows Biomarkers May Hold Clue in Treating Aggressive Prostate Cancer  | Newswise

New Breast Imaging Legislation to Help Thousands Across Wisconsin | Newswise

Newswise — Susan G. Komen®, the world’s leading breast cancer organization commends Representative Cindi Duchow (R–Delafield) and Senator Rachael Cabral-Guevara (R–Appleton) for introducing legislation to ensure that everyone has equitable access to diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening.   In Wisconsin, more than…

Read More
Considering Cases with Rheumatic Reactions to Cancer Immunotherapy | Newswise

Considering Cases with Rheumatic Reactions to Cancer Immunotherapy | Newswise

Newswise — Philadelphia, PA  — The prevalence and severity of rheumatic adverse reactions in cancer immunotherapy is significantly underestimated, due to the lack of standardized screening protocols for malignancies in patients with autoimmune disorders. In response to the need for data collection and diagnostic criteria, researchers have developed a trans-disciplinary approach to safeguard those patients…

Read More